BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25897103)

  • 21. Preoperative platelet-lymphocyte ratio is an independent factor of poor prognosis after curative surgery for colon cancer.
    Bailon-Cuadrado M; Choolani-Bhojwani E; Tejero-Pintor FJ; Sanchez-Gonzalez J; Rodriguez-Lopez M; Perez-Saborido B; Marcos-Rodriguez JL
    Updates Surg; 2018 Mar; 70(1):33-39. PubMed ID: 29222632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel screening test for colon cancer: Talin-1.
    Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facile and ultrasensitive fluorescence sensor platform for tumor invasive biomaker β-glucuronidase detection and inhibitor evaluation with carbon quantum dots based on inner-filter effect.
    Lu S; Li G; Lv Z; Qiu N; Kong W; Gong P; Chen G; Xia L; Guo X; You J; Wu Y
    Biosens Bioelectron; 2016 Nov; 85():358-362. PubMed ID: 27196253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced activity of serum beta-glucuronidase in Marfan syndrome.
    Nakashima Y
    Angiology; 1986 Aug; 37(8):576-80. PubMed ID: 3740547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer.
    Padín-Iruegas ME; Herranz-Carnero M; Aguin-Losada S; Brozos-Vazquez E; Anido-Herranz U; Antunez-Lopez JR; Ruibal-Morell A; López-López R
    Oncol Rep; 2013 Jun; 29(6):2467-72. PubMed ID: 23545848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
    Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
    Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of the method for α-l-fucosidase, β-d-galactosidase and β-d-glucuronidase determination in serum from hemolyzed blood.
    Chojnowska S; Ptaszyńska-Sarosiek I; Kępka A; Szajda SD; Waszkiewicz N; Zwierz K
    Adv Med Sci; 2018 Sep; 63(2):306-311. PubMed ID: 29885630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
    Perez CA; Ravindranath MH; Gupta RK; Tollenaar RA; van de Velde CJ; Wood TF; Soh D; Morton DL; Bilchik AJ
    Cancer J; 2002; 8(1):55-61. PubMed ID: 11898807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].
    Kargi A; Yalcin AD; Erin N; Savas B; Polat HH; Gorczynski RM
    Clin Lab; 2012; 58(9-10):1103-7. PubMed ID: 23163132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer.
    Kargi A; Yalcin AD; Erin N; Savas B; Polat HH; Gorczynski RM
    Clin Lab; 2012; 58(5-6):501-5. PubMed ID: 22783581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysosomal exoglycosidases and cathepsin D in colon adenocarcinoma.
    Waszkiewicz N; Zalewska-Szajda B; Szajda SD; Kępka A; Waszkiewicz M; Roszkowska-Jakimiec W; Wojewódzka-Żeleźniakowicz M; Milewska AJ; Dadan J; Szulc A; Zwierz K; Ladny JR
    Pol Arch Med Wewn; 2012; 122(11):551-6. PubMed ID: 23111620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance of TIMP-1 level in serum and its immunohistochemical expression in colorectal cancer patients.
    Niewiarowska K; Pryczynicz A; Dymicka-Piekarska V; Gryko M; Cepowicz D; Famulski W; Kemona A; Guzińska-Ustymowicz K
    Pol J Pathol; 2014 Dec; 65(4):296-304. PubMed ID: 25693084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
    Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
    Lin HH; Chang CC; Yang SH; Chang SC; Chen WS; Liang WY; Lin JK; Jiang JK
    World J Surg Oncol; 2016 Mar; 14():84. PubMed ID: 26976278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
    Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
    Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Tedesco M; Grassi A; Casale V; Cavaliere F; Greiner JW
    J Surg Oncol Suppl; 1991; 2():16-20. PubMed ID: 1892526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.
    Tobin P; Clarke S; Seale JP; Lee S; Solomon M; Aulds S; Crawford M; Gallagher J; Eyers T; Rivory L
    Br J Clin Pharmacol; 2006 Jul; 62(1):122-9. PubMed ID: 16842384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients.
    Hamed MA; Ahmed SA; Khaled HM
    Mem Inst Oswaldo Cruz; 2011 May; 106(3):322-9. PubMed ID: 21655820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.